MAPT and Alzheimer disease: Core Molecular Mechanisms of AD Treatment encompass strategies ranging from the clearance of pathogenic protein aggregates and oligomers (Aβ and Tau), modulation of protein phosphorylation via O-GlcNAcylation, and counteracting neuroinflammation and oxidative stress, to the activation of beneficial cellular responses, such as microglial phagocytosis.